Fujifilm Diosynth Biotechnologies and Piramal Healthcare in the U.K. are pooling their expertise to offer what they claim is a seamless contract development and manufacturing service for antibody drug conjugates (ADCs).
Assay can be used with the Abbott m2000 system to understand response to treatment.
RELAX-AHF-2 study failed to meet primary endpoints
Enzymatic synthesis of psilocybin, the active ingredient of psychedelic mushrooms, has been detailed
Merck & Co. plans to acquire Tilos Therapeutics for up to $773 million, in a deal designed to expand the buyer’s cancer, fibrosis, and autoimmune disease pipelines with therapies targeting the latent TGFβ complex.
Increased investment round follows recently awarded €1.6M grant from Flanders Government.
Researchers develop novel technique to induce a specific type of cell death in brain cancer cells from mice
Eurostars-funded Kinomed Partnership will exploit expertise of KinaseDetect, Iota Pharmaceuticals and SARomics Biostructures.
Biotie has changed its strategy of focusing on locomotive diseases to fibrotic diseases.